Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.75
+1.14 (20.32%)
At close: Mar 6, 2026, 4:00 PM EST
6.90
+0.15 (2.22%)
After-hours: Mar 6, 2026, 7:55 PM EST
Solid Biosciences Employees
Solid Biosciences had 100 employees as of December 31, 2024. The number of employees increased by 12 or 13.64% compared to the previous year.
Employees
100
Change (1Y)
12
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,671,350
Market Cap
525.89M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 353 |
| 4D Molecular Therapeutics | 227 |
| Entrada Therapeutics | 152 |
| Century Therapeutics | 150 |
| Lineage Cell Therapeutics | 77 |
| Assembly Biosciences | 73 |
| Altimmune | 59 |
| Anavex Life Sciences | 34 |
SLDB News
- 1 day ago - Solid Biosciences Announces Oversubscribed $240 Million Private Placement - GlobeNewsWire
- 1 day ago - Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewsWire
- 5 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 26 days ago - Solid Biosciences: Positive FDA Meeting For SGT-003 Sets Up Next Milestones - Seeking Alpha
- 26 days ago - Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy - GlobeNewsWire
- 4 weeks ago - Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 7 weeks ago - Solid Biosciences Inc. (SLDB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha